tm
Seeing Is Believing
tm
Seeing Is Believing
AVIR is currently covered by 1 analysts with an average price target of $7. This is a potential upside of $3.18 (33.84%) from yesterday's end of day stock price of $5.23.
Atea Pharmaceuticals 's activity chart (see below) currently has 13 price targets and 14 ratings on display. The stock rating distribution of AVIR is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 62.22% with an average time for these price targets to be met of 83.67 days.
Highest price target for AVIR is $7, Lowest price target is $7, average price target is $7.
Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 13-Aug-2026. First documented stock forecast 24-Nov-2020.
Currently out of the existing stock ratings of AVIR, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 11-Apr-2025
$7
$1.69 (31.83%)
$6
1 months 2 days ago
(13-Aug-2026)
6/10 (60%)
$1.93 (38.07%)
98
Hold Since 02-Mar-2022
$8
3 years 1 months 5 days ago
(10-Aug-2023)
3/5 (60%)
$4.32 (117.39%)
55
What is AVIR (Atea Pharmaceuticals ) average time for price targets to be met?
Which analyst most recently updated their price target on AVIR (Atea Pharmaceuticals )?
Which analyst has the current lower performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on AVIR (Atea Pharmaceuticals )?
Which analyst is the currently most bullish on AVIR (Atea Pharmaceuticals )?
Which analyst is the currently most reserved on AVIR (Atea Pharmaceuticals )?
